The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. [electronic resource]
Producer: 20160721Description: 318-28 p. digitalISSN:- 0392-856X
- Arthritis, Rheumatoid -- drug therapy
- Cytokines -- physiology
- Humans
- Janus Kinases -- antagonists & inhibitors
- Lymphocyte Subsets -- drug effects
- Neutrophils -- drug effects
- Piperidines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- Signal Transduction -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.